{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:55:12Z","timestamp":1790618112022,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003466","name":"University of Leeds Faculty of Medicine and Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003466","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.molimm.2026.09.004","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T19:42:30Z","timestamp":1789760550000},"page":"89-99","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Adhiron binders as molecular tools for inhibiting activation dependent, IL-7 mediated long-term survival of CD4+ T-cells"],"prefix":"10.1016","volume":"199","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6812-0998","authenticated-orcid":false,"given":"Daniel","family":"Perez-Witzke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Tiede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8533-2254","authenticated-orcid":false,"given":"Min","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Guillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rekha","family":"Parmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James\u00a0I.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3969-7701","authenticated-orcid":false,"given":"Frederique","family":"Ponchel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2026.09.004_bib1","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1084\/jem.20040789","article-title":"Activation of PI3K is indispensable for interleukin 7\u2013mediated viability, proliferation, glucose use, and growth of T cell acute lymphoblastic leukemia cells","volume":"200","author":"Barata","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molimm.2026.09.004_bib2","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1038\/s41467-018-06804-y","article-title":"IL-7 receptor blockade blunts antigen-specific memory T cell responses and chronic inflammation in primates","volume":"9","author":"Belarif","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molimm.2026.09.004_bib3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.smim.2012.04.010","article-title":"IL-7 signaling and CD127 receptor regulation in the control of T cell homeostasis","volume":"24","author":"Carrette","year":"2012","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.molimm.2026.09.004_bib4","doi-asserted-by":"crossref","first-page":"C1560","DOI":"10.1152\/ajpcell.00506.2009","article-title":"Interleukin-7 mediates glucose utilization in lymphocytes through transcriptional regulation of the hexokinase II gene","volume":"298","author":"Chehtane","year":"2010","journal-title":"Am. J. Physiol. -Cell. Physiol."},{"key":"10.1016\/j.molimm.2026.09.004_bib5","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1182\/blood-2006-11-055673","article-title":"Prevention of graft-versus-host disease by anti\u2013IL-7R\u03b1 antibody","volume":"110","author":"Chung","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2026.09.004_bib6","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/bcp.13748","article-title":"Anti-IL-7 receptor \u03b1 monoclonal antibody (GSK2618960) in healthy subjects \u2013 a randomized, double-blind, placebo-controlled study","volume":"85","author":"Ellis","year":"2019","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.molimm.2026.09.004_bib7","doi-asserted-by":"crossref","unstructured":"Flynn, A.J., Derry, A., Debski-Antoniak, O., Muench, S.P., Fontana, J., Simmons, K., 2025. Adhirons are efficient tools to guide antiviral ligand discovery. https:\/\/doi.org\/10.1101\/2025.05.13.653658.","DOI":"10.1101\/2025.05.13.653658"},{"key":"10.1016\/j.molimm.2026.09.004_bib8","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1038\/s41467-024-46321-9","article-title":"Human IgG Fc-engineering for enhanced plasma half-life, mucosal distribution and killing of cancer cells and bacteria","volume":"15","author":"Foss","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molimm.2026.09.004_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.109251","article-title":"Targeting Tenascin-C-Toll-like Receptor 4 signalling with Adhiron-derived small molecules - a viable strategy for reducing fibrosis in systemic sclerosis","volume":"167","author":"Gaule","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.molimm.2026.09.004_bib10","article-title":"Targeting Tenascin-C-Toll-like Receptor 4 signalling with Adhiron-derived small molecules - a viable strategy for reducing fibrosis in Systemic Sclerosiss","author":"Gaule","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.molimm.2026.09.004_bib11","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.clim.2014.02.007","article-title":"Renegade homeostatic cytokine responses in T1D: drivers of regulatory\/effector T cell imbalance","volume":"151","author":"Gupta","year":"2014","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.molimm.2026.09.004_bib12","article-title":"Systematic analysis of Fc mutations designed to reduce binding to Fc-gamma receptors","volume":"16","author":"Hale","year":"2024","journal-title":"mAbs"},{"key":"10.1016\/j.molimm.2026.09.004_bib13","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1002\/art.27578","article-title":"Blockade of the interleukin-7 receptor inhibits collagen-induced arthritis and is associated with reduction of T cell activity and proinflammatory mediators","volume":"62","author":"Hartgring","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.molimm.2026.09.004_bib14","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1002\/(SICI)1521-4141(199810)28:10<3057::AID-IMMU3057>3.0.CO;2-Z","article-title":"IL-7 promotes the survival and maturation but not differentiation of human post-thymic CD4+ T cells","volume":"28","author":"Hassan","year":"1998","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.molimm.2026.09.004_bib15","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1038\/s41467-021-24316-0","article-title":"RAS-inhibiting biologics identify and probe druggable pockets including an SII-\u03b13 allosteric site","volume":"12","author":"Haza","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molimm.2026.09.004_bib16","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.126054","article-title":"Immunomodulatory activity of humanized anti\u2013IL-7R monoclonal antibody RN168 in subjects with type 1 diabetes","volume":"4","author":"Herold","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.molimm.2026.09.004_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-79357-4","article-title":"Generating and validating renewable affimer protein binding reagents targeting SH2 domains","volume":"14","author":"Heseltine","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molimm.2026.09.004_bib18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jim.2010.01.007","article-title":"Stromal cell independent B cell development in vitro: generation and recovery of autoreactive clones","volume":"354","author":"Holl","year":"2010","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.molimm.2026.09.004_bib19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/eji.200738044","article-title":"Fine-tuning CD4+ central memory T cell heterogeneity by strength of stimulation","volume":"38","author":"Kalia","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.molimm.2026.09.004_bib20","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1084\/jem.20030735","article-title":"Interleukin 7 regulates the survival and generation of memory CD4 cells","volume":"198","author":"Kondrack","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molimm.2026.09.004_bib21","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.1074\/jbc.M209015200","article-title":"Analysis of \u03b3c-family cytokine target genes","volume":"278","author":"Kovanen","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molimm.2026.09.004_bib22","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1222303110","article-title":"Soluble IL7R\u03b1 potentiates IL-7 bioactivity and promotes autoimmunity","volume":"110","author":"Lundstr\u00f6m","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.molimm.2026.09.004_bib23","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1172\/JCI66287","article-title":"IL-7 receptor blockade following T cell depletion promotes long-term allograft survival","volume":"124","author":"Mai","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molimm.2026.09.004_bib24","doi-asserted-by":"crossref","first-page":"9632","DOI":"10.1002\/chem.201701321","article-title":"Rational design of nanobody80 loop peptidomimetics: towards biased \u03b22 adrenergic receptor ligands","volume":"23","author":"Martin","year":"2017","journal-title":"Chem. \u2013 Eur. J."},{"key":"10.1016\/j.molimm.2026.09.004_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113184","article-title":"Affimer-mediated locking of p21-activated kinase 5 in an intermediate activation state results in kinase inhibition","volume":"42","author":"Martin","year":"2023","journal-title":"Cell. Rep."},{"key":"10.1016\/j.molimm.2026.09.004_bib26","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nri2023","article-title":"Interleukin-7 receptor expression: intelligent design","volume":"7","author":"Mazzucchelli","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.molimm.2026.09.004_bib27","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1073\/pnas.1116582109","article-title":"Structural reorganization of the interleukin-7 signaling complex","volume":"109","author":"McElroy","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.molimm.2026.09.004_bib28","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1002\/art.38338","article-title":"Thymic stromal lymphopoietin, a novel proinflammatory mediator in rheumatoid arthritis that potently activates CD1c+ myeloid dendritic cells to attract and stimulate T cells","volume":"66","author":"Moret","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.molimm.2026.09.004_bib29","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3390\/ph5020209","article-title":"Structure based antibody-like peptidomimetics","volume":"5","author":"Murali","year":"2012","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.molimm.2026.09.004_bib30","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.4049\/jimmunol.172.4.2021","article-title":"Visualizing the site and dynamics of IgG salvage by the MHC Class I-related receptor, FcRn","volume":"172","author":"Ober","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2026.09.004_bib31","doi-asserted-by":"crossref","first-page":"12668","DOI":"10.1073\/pnas.1203692109","article-title":"IL-7 receptor blockade reverses autoimmune diabetes by promoting inhibition of effector\/memory T cells","volume":"109","author":"Penaranda","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.molimm.2026.09.004_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2021.113020","article-title":"Development of a long-term, IL7 dependent cell death rescue assay in CD4+ T-cells","volume":"493","author":"Perez-Witzke","year":"2021","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.molimm.2026.09.004_bib33","first-page":"31","article-title":"IL-7 in rheumatoid arthritis: pathogenesis, biomarker and rationale for anti-IL-7 therapy","author":"Ponchel","year":"2014","journal-title":"Adv. Med. Biol."},{"key":"10.1016\/j.molimm.2026.09.004_bib34","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jneuroim.2010.02.014","article-title":"Alternative splicing of interleukin-7 (IL-7) and interleukin-7 receptor alpha (IL-7R\u03b1) in peripheral blood from patients with multiple sclerosis (MS)","volume":"222","author":"Rane","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.molimm.2026.09.004_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.110461","article-title":"Affimer reagents enable targeted delivery of therapeutic agents and RNA via virus-like particles","volume":"27","author":"Roberts","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.molimm.2026.09.004_bib36","doi-asserted-by":"crossref","unstructured":"Roberts*, J.P., Holder*, J., Shami-Inkindi, G.B., Mohan, I.A., Cordell, P.A., Miles, J.A., Blinkhome, F., Tiede, C., Richards, M.W., Gaule, T.G., Smith, C.E.L., Gergely, F., Bayliss, R., Johnson, C.A., Tomlinson, D., 2025. Synthetic protein binders reveal a cryptic regulatory pocket on Aurora A for selective allosteric inhibition. https:\/\/doi.org\/10.21203\/rs.3.rs-7565154\/v1.","DOI":"10.21203\/rs.3.rs-7565154\/v1"},{"key":"10.1016\/j.molimm.2026.09.004_bib37","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1707856115","article-title":"Affimer proteins inhibit immune complex binding to Fc\u03b3RIIIa with high specificity through competitive and allosteric modes of action","volume":"115","author":"Robinson","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.molimm.2026.09.004_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105325","article-title":"Affimer\u201d synthetic protein scaffolds block oxidized LDL binding to the LOX-1 scavenger receptor and inhibit ERK1\/2 activation","volume":"299","author":"Roper","year":"2023","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molimm.2026.09.004_bib39","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1084\/jem.20052187","article-title":"Autoimmune arthritis associated with mutated interleukin (IL)-6 receptor gp130 is driven by STAT3\/IL-7\u2013dependent homeostatic proliferation of CD4+ T cells","volume":"203","author":"Sawa","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molimm.2026.09.004_bib40","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/protein\/gzr019","article-title":"Structure\u2212function studies of an engineered scaffold protein derived from Stefin A. II: development and applications of the SQT variant","volume":"24","author":"Stadler","year":"2011","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.molimm.2026.09.004_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.564","article-title":"The use of a neutral peptide aptamer scaffold to anchor BH3 peptides constitutes a viable approach to studying their function","volume":"5","author":"Stadler","year":"2014","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.molimm.2026.09.004_bib42","doi-asserted-by":"crossref","first-page":"8691","DOI":"10.1074\/jbc.M113.449918","article-title":"Membrane microdomains and cytoskeleton organization shape and regulate the IL-7 receptor signalosome in human CD4 T-cells","volume":"288","author":"Tamarit","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molimm.2026.09.004_bib43","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.3390\/biom14081040","article-title":"Targeting Grb2 SH3 domains with affimer proteins provides novel insights into ras signalling modulation","volume":"14","author":"Tang","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.molimm.2026.09.004_bib44","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.24903","article-title":"Affimer proteins are versatile and renewable affinity reagents","volume":"6","author":"Tiede","year":"2017","journal-title":"eLife"},{"key":"10.1016\/j.molimm.2026.09.004_bib45","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/protein\/gzu007","article-title":"Adhiron: a stable and versatile peptide display scaffold for molecular recognition applications","volume":"27","author":"Tiede","year":"2014","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.molimm.2026.09.004_bib46","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14937","article-title":"Structure and antagonism of the receptor complex mediated by human TSLP in allergy and asthma","volume":"8","author":"Verstraete","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molimm.2026.09.004_bib47","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1208\/s12248-019-0401-3","article-title":"Model-based characterization of the pharmacokinetics, target engagement biomarkers, and immunomodulatory activity of PF-06342674, a humanized mAb against IL-7 receptor-\u03b1, in adults with type 1 diabetes","volume":"22","author":"Williams","year":"2020","journal-title":"AAPS J."},{"key":"10.1016\/j.molimm.2026.09.004_bib48","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1182\/blood-2007-06-096297","article-title":"IL-7 promotes Glut1 trafficking and glucose uptake via STAT5-mediated activation of Akt to support T-cell survival","volume":"111","author":"Wofford","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2026.09.004_bib49","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1182\/bloodadvances.2024012689","article-title":"Affimer reagents as tool molecules to modulate platelet GPVI-ligand interactions and specifically bind GPVI dimer","volume":"8","author":"Xu","year":"2024","journal-title":"Blood Adv."},{"key":"10.1016\/j.molimm.2026.09.004_bib50","doi-asserted-by":"crossref","first-page":"19399","DOI":"10.1074\/jbc.M112.368647","article-title":"Soluble Monomeric IgG1 Fc","volume":"287","author":"Ying","year":"2012","journal-title":"J. Biol. Chem."}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589026002063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589026002063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:58:06Z","timestamp":1790614686000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589026002063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":50,"alternative-id":["S0161589026002063"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2026.09.004","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adhiron binders as molecular tools for inhibiting activation dependent, IL-7 mediated long-term survival of CD4+ T-cells","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2026.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}